Drug for the treatment of diabetes Avandia

Safety of the drug for the treatment of diabetes, Avandia, developed by British company cheap avandia, has once again been criticized. German researchers published the results of July 18 cheap avandia, which deals a new blow to the drug, which is the second largest revenue generated by the product of Cheap Avandia. Having studied the data of 18 clinical trials involving 8,000 patients, researchers found little evidence that taking cheap avandia diabetic extended life or improved quality, and concluded that the drug can complicate the course of the disease. Bernd Richter, who led the research of Heinrich-Heine University in Dusseldorf, questioned the ethics of conducting further clinical trials cheap avandia at a time when available "less dangerous" alternative medicine.

The dispute goes to a decisive stage on 30 July, when the advisers of the U.S. control over the quality of cheap avandia and food products, FDA, will meet to discuss security cheap Avandia. Kroll was confident that the company will be able to present at the meeting evidence of his innocence. Meanwhile, Glaxo Cheap Avandia received a warning that many patients and their relatives are ready to submit it to the court. The first lawsuit filed over CheapAvandia widow and son of a resident of Texas, who took the drug last month and died of a heart attack.